Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9665 - 9672 of 11617 results
The Supreme Court Continues to Punt on False Claims Cases
October 7, 2014| Blog| Viewpoint
FDA Announces More Changes to FSMA Implementation Rules
October 6, 2014| Blog| Viewpoint
Tenth Circuit Affirms Class Certification and Price Fixing Verdict Against Dow Chemical
October 6, 2014| Advisory| Viewpoint
Federal Judge Rules to Allow Extrapolation on More Than 50,000 Patient Admissions in FCA Case
October 6, 2014| Blog| Viewpoint
Taking 221(g) Administrative Processing Too Far?
October 6, 2014| Blog| Viewpoint
Did the USPTO Really Improve the 'After Final Consideration Pilot'?
October 3, 2014| Blog| Viewpoint
Who Hurts More? Another Battle in the Non-compete Wars
October 2, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.